Clinical trial
Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or…
NCT00157339 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00157339 |
|---|---|
| Title | Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD |
| Official title | A Pivotal, Open-Label, Parallel Study to Evaluate the Safety and Efficacy of Human Insulin Inhalation Powder (HIIP) Compared to Injectable Insulin in Patients With Diabetes and COPD or Asthma |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Alkermes, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Asthma, Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | Human Insulin Inhalation Powder, injected insulin |
| Enrollment | 299 |
| Start date | Aug 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Sep 17, 2019 |
| Countries | Argentina, Bulgaria, Canada, Chile, Colombia, Croatia, Hong Kong, Hungary, India, Mexico, Philippines, Puerto Rico and 4 more |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: